BNP PARIBAS ARBITRAGE/CALL/DIASORIN/110/0.1/20.03.25

BNP PARIBAS ARBITRAGE/CALL/DIASORIN/110/0.1/20.03.25 Stock

P24RN0

NLBNPIT24RN0

Market Closed - Borsa Italiana 16:04:59 2024-07-05 EDT
0.688 ^EUR	-2.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Chart BNP PARIBAS ARBITRAGE/CALL/DIASORIN/110/0.1/20.03.25

Latest news about DIASORIN S.P.A.

Futures await lists up; Labour wins in UK	07-05	AN
Mib rises above 34,100 points; FinecoBank on top	07-04	AN
Mib rises and pegs 34,000; FinecoBank bullish	07-04	AN
Milan stock market starts strong, Ftse Mib above 34,000 points on mid-June high, banks good	07-04	RE

More news

Quotes 5-day view

Date	Price	Change
24-07-05	0.682	-3.81%
24-07-04	0.709	+9.08%
24-07-03	0.65	+12.26%
24-07-02	0.579	+25.05%

Real-time Borsa Italiana

Last update July 05, 2024 at 04:04 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P24RN0
ISIN	NLBNPIT24RN0
Date issued	2024-07-01
Strike	110 €
Maturity	2025-03-20 (257 Days)
Parity	10 : 1
Emission price	- €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	0.715 €
Lowest since issue	0.396 €
Spread	0.15 €
Spread %	19.63%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

99.42 EUR

Average target price

101.7 EUR

Spread / Average Target

+2.25%

Consensus